论文部分内容阅读
目的探讨持续有创颅内压监测应用于高血压性脑出血治疗的价值。方法将76例高血压性脑出血患者按照随机原则分为创新组与传统组各38例,传统组采用常规性监测方法和治疗方法治疗,创新组患者则在传统治疗的基础上加以持续有创颅内压监测,并由医院专业医护人员就2组患者接受治疗后的临床疗效、甘露醇使用量和并发症情况进行对比分析。结果创新组患者的临床总有效率为97.37%高于传统组患者的71.05%,差异有统计学意义(P<0.05)。创新组的甘露醇用量少于传统组,差异均有统计学意义(P<0.05)。创新组患者的并发症发生率为2.63%低于传统组的36.84%,差异有统计学意义(P<0.05)。结论在给予高血压性脑出血患者常规监测和常规治疗的前提下进行持续有创颅内压监测,可进一步改善患者病情,并有效减少并发症的发生,从而有利于提高临床疗效。
Objective To investigate the value of continuous invasive intracranial pressure monitoring in the treatment of hypertensive intracerebral hemorrhage. Methods 76 patients with hypertensive intracerebral hemorrhage were randomly divided into two groups according to the randomization principle: 38 patients in the traditional medicine group and traditional medicine group. Conventional monitoring methods and treatment methods were used in the traditional medicine group. Patients in the innovative group were continually invasive Intracranial pressure monitoring, by the hospital professional health care workers on the two groups of patients after treatment of clinical efficacy, mannitol use and complications were compared. Results The total effective rate of patients in the innovative group was 97.37%, which was significantly higher than that in the traditional group (71.05%), the difference was statistically significant (P <0.05). The mannitol consumption in the innovative group was less than that in the traditional group, with significant differences (P <0.05). The incidence of complications in patients in the innovation group was 2.63% lower than that in the traditional group (36.84%), the difference was statistically significant (P <0.05). CONCLUSION: Continuous intracranial pressure monitoring in patients with hypertensive intracerebral hemorrhage under routine monitoring and routine treatment can further improve the patient’s condition and reduce the incidence of complications, which is beneficial to improve the clinical efficacy.